Better Vision, Faster

Founded in 2021 through the strategic merger of VIS LLC and NTK Enterprises, Inc., VIS, Inc. combines innovation and expertise to redefine optical healthcare. This merger provided VIS with full ownership of the intellectual property (IP) behind Opti-K™, a patented laser-based optical procedure and proprietary system for the treatment of presbyopia. Opti-K™ is just the beginning of VIS’s ambitious acquisition strategy.

At VIS, our mission is to revolutionize vision care by acquiring, developing, and commercializing proven medical laser-based optical devices and procedures. Our goal is to build a diverse portfolio of innovative solutions that deliver safe, fast, and affordable treatments with outstanding results.

Future Focus

With a team of seasoned professionals and a proven track record in product acquisition, development, market entry, and commercialization, VIS is committed to expanding its portfolio of laser-based optical solutions. Our vision is to empower ophthalmologists with state-of-the-art tools to enhance patient outcomes and transform lives.

At VIS, we understand that sight is one of our most precious senses—the one people fear losing the most. Our mission is to commercialize and scale proprietary laser-based optical systems, empowering ophthalmologists to provide safe, fast, and affordable treatments that deliver exceptional results.

DISCLAIMER: The VIS Optimal Keratoplasty (Opti-K™) System is an investigational device, and it is not available for sale or use in the United States.

VIS, Inc.
2800 Dallas Parkway, Suite 100
Plano, TX 75093
United States of America
Monday - Friday 8:00 AM - 6:00 PM
[email protected]
+1 561 819 8300